EOSINOPHILIC ESOPHAGITIS (EOE)
Clinical trials for EOSINOPHILIC ESOPHAGITIS (EOE) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ESOPHAGITIS (EOE) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ESOPHAGITIS (EOE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with swallowing trouble: drug targets esophagus inflammation
Disease control CompletedThis study tested a drug called dupilumab in 102 children with active eosinophilic esophagitis (EoE), a condition where the esophagus becomes inflamed, making swallowing painful. The goal was to see if dupilumab could reduce inflammation better than a placebo after 16 weeks. Rese…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Massive study probes cancer risk in eosinophilic esophagitis patients
Knowledge-focused CompletedThis study looked at health records from about 100 million people to find out if those with eosinophilic esophagitis (EoE) are more likely to develop esophageal cancer. The researchers wanted to see if any increased risk is due to EoE itself or to other common conditions like GER…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC